echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > Blood Cancer J: The value of the MASS staging system in the prognosis of the new diagnosis of multiple myeloma

    Blood Cancer J: The value of the MASS staging system in the prognosis of the new diagnosis of multiple myeloma

    • Last Update: 2022-09-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    To guide treatment decisions for multiple myeloma (MM), there are multiple risk stratification systems in place to distinguish between different risk levels in patients at the time of diagnosis, including ISS and R-ISS
    。 R-ISS includes elevated lactate dehydrogenase (LDH) and high-risk cytogenetic abnormalities (HRCA) such as del(17p), t(4;14), and t(14;16), but the influence or weight of various baseline risk factors in estimating outcomes in MM patients may change as MM treatment patterns shift, such as other high-risk cytogenetic abnormalities that are partially not included in R-ISS (e.


    In order to further test the prognostic value of the MASS staging system in newly diagnosed MM patients in China, Professor Dai Yun and Professor Jin Fengyan of the First Hospital of Jilin University led the analysis of clinical retrospective data of MM patients in 7 centers in China from November 27, 2009 to November 20, 2019, and the results of the study were published in the Blood Cancer Journal
    .


    References

    Peiyu Yang, Fan Zhou, Yujun Dong,et al.


     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.